Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).
Diabetes is too serious to be left solely to the medical professionals, Jitendra Singh, Union minister for earth sciences and science and technology, said as he advocated for increasing public-private ...